Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2677 |
|
Actual shortage: | 255 (10%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2413 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (9%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-INDOMETHACIN | 25MG | CAPSULE | Resolved | 2022-10-17 | 2023-06-09 | 172010 |
TEVA-PIROXICAM | 20MG | CAPSULE | Resolved | 2022-10-17 | 2023-10-19 | 172024 |
TEVA-SERTRALINE | 50MG | CAPSULE | Resolved | 2022-10-28 | 2023-01-18 | 173000 |
TEVA-CEPHALEXIN | 250MG | CAPSULE | Resolved | 2022-10-28 | 2023-10-03 | 173007 |
TEVA-AMPICILLIN | 500MG | CAPSULE | Resolved | 2022-10-28 | 2022-11-12 | 173034 |
TEVA-RAMIPRIL | 10MG | CAPSULE | Resolved | 2022-11-14 | 2023-02-02 | 174604 |
NOVAMOXIN | 500MG | CAPSULE | Resolved | 2022-12-01 | 2023-07-05 | 176767 |
NOVAMOXIN | 250MG | CAPSULE | Resolved | 2022-12-01 | 2023-06-09 | 176770 |
TEVA-NABILONE | 0.5MG | CAPSULE | Resolved | 2022-12-01 | 2023-04-28 | 176836 |
TEVA-NABILONE | 1.0MG | CAPSULE | Resolved | 2022-12-01 | 2023-04-28 | 176839 |
TEVA-FLUVASTATIN | 20MG | CAPSULE | Resolved | 2022-12-01 | 2023-04-28 | 176848 |
TEVA-FLUVASTATIN | 40MG | CAPSULE | Resolved | 2022-12-01 | 2024-01-11 | 176851 |
TEVA-NITROFURANTOIN | 50MG | CAPSULE | Resolved | 2022-12-22 | 2023-02-16 | 179191 |
TEVA-RAMIPRIL | 10MG | CAPSULE | Resolved | 2022-12-22 | 2023-04-28 | 179297 |
TEVA-GABAPENTIN | 400MG | CAPSULE | Resolved | 2023-01-19 | 2023-04-28 | 181617 |
TEVA-TEMOZOLOMIDE | 250MG | CAPSULE | Resolved | 2023-01-19 | 2023-04-28 | 181628 |
TEVA-GABAPENTIN | 100MG | CAPSULE | Resolved | 2023-02-02 | 2023-02-09 | 183422 |
TEVA-MEXILETINE | 200MG | CAPSULE | Resolved | 2023-02-09 | 2023-06-09 | 184186 |
TEVA-GABAPENTIN | 400MG | CAPSULE | Resolved | 2023-02-09 | 2023-04-28 | 184189 |
TEVA-DUTASTERIDE | 0.5MG | CAPSULE | Actual shortage | 2023-02-09 | 2024-04-25 | 184216 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-QUININE | 300MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104294 |
TEVA-TRANDOLAPRIL | 0.5MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120021 |
TEVA-TRANDOLAPRIL | 1MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120024 |
TEVA-TRANDOLAPRIL | 2MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120027 |
TEVA-TRANDOLAPRIL | 4MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120030 |
TEVA-PREGABALIN | 75MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120033 |
ACT CELECOXIB | 100MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123648 |
ACT CELECOXIB | 200MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123651 |
TEVA-QUININE | 200MG | CAPSULE | Discontinued | 2020-10-08 | 2020-10-09 | 125976 |
TEVA-CEPHALEXIN | 500MG | CAPSULE | Discontinued | 2020-10-08 | 2020-10-09 | 125979 |
ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2020-10-15 | 2020-10-15 | 126452 |
ACT CELECOXIB | 200MG | CAPSULE | Discontinued | 2021-02-12 | 2021-02-12 | 133874 |
ACT CELECOXIB | 100MG | CAPSULE | Discontinued | 2021-02-12 | 2021-02-12 | 133880 |
ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2021-09-23 | 2021-09-23 | 146066 |
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 |